Searched for
SAGENT PHARMA
Kedaara, TA Associates vie for minority stake in Sagent PharmaKedaara Capital and TA Associates are in talks to acquire a significant minority stake in Sagent Pharma, valued at $500-600 million. Invest...- Smartkarma Research: APAC Healthcare Series - Top picks are poised for multi-year growthGland Pharma’s near-term focus remains on establishing a strong portfolio of complex injectables. The company is working on development of ...
- Aurobindo, Intas in race for $1 billion buyout of Teva UK, submit binding offersIf successful, this would be Aurobindo's largest ever acquisition, surpassing its $132.5 mn purchase of US vitamin maker Natrol Inc in 2014.
- DRL, Cipla, Aurobindo among others to buy products from TevaThe remedy requires Teva to divest the drug portfolio to 11 firms and marks the largest drug divestiture order in an FTC pharmaceutical mer...
- Torrent, Dr Reddy’s, Aurobindo, Cipla, Lupin in race to buy SagentValuation is expected to be upwards of $500 million (Rs 3,400 crore), for which large generic drug makers and financial investors like glob...
- Mylan’s Agila Specialties deal faces riders from US watchdogUS-based generic giant Mylan Inc’s $1.85-billion bid to acquire Indian drugmaker Agila Specialties now faces fresh riders, this time from i...
- Indian drug companies like Glenmark, Dr Reddy's, Sun Pharma break into world’s fastest growing listThe club of the fastest growing generic companies in the world is dominated by US companies , led by US-based Sagent Pharma, which witnesse...
- Claris gets nod for Rs 300-crore IPOClaris Lifesciences Ltd, has finally received approval from SEBI for its maiden public issue to raise Rs 300 crore.
Load More